Skip to main content
. 2013 Aug 2;31(9):799–806. doi: 10.1007/s40273-013-0075-0

Table 4.

Costs of cohorts in first year of disability level ($US, year 2010 values)

Newly diagnosed cohorta PDAAD cohorta PDINST cohorta
PD Control p value PD Control p value PD Control p value
Inpatient 1,446 (13,603) 1,233 (10,346) <0.0001 14,111 (92,001) 1,342 (9,142) <0.001 15,026 (33,403) 1,829 (14,920) <0.001
ED 182 (1,127) 100 (562) 0.0046 350 (933) 98 (651) <0.001 744 (2,150) 121 (628) <0.001
Outpatient 4,668 (6,300) 2,530 (9,348) <0.0001 9,184 (15,244) 2,524 (7,386) <0.001 11,527 (25,480) 2,681 (6,576) <0.001
Prescription drugs 2,872 (2,866) 1,221 (2,571) <0.0001 7,228 (5,183) 1,368 (2,855) <0.001 8,781 (13,820) 1,448 (3,120) <0.001
AADs 2 (77) 927 (2,958) 1 (22) <0.001 366 (1,387) 3 (110) <0.001
LTCb 6 (159) 16 (590) 0.1759 7,061 (13,247) 14 (465) <0.001
Total 9,175 (17,006) 5,103 (16,340) <0.0001 31,800 (99,695) 5,333 (14,499) <0.001 43,506 (63,125) 6,096 (18,779) <0.001

aAll cost values are reported as mean (SD)

bLTC is defined as costs incurred where either the place of service or provider type was listed an extended care facility, a nursing home, or a skilled nursing facility

AADs ambulatory assistance devices, ED emergency department, LTC long-term care, PD Parkinson’s disease, PDAAD PD and ambulatory assistance device, PDINST PD and institutionalization, SD standard deviation